Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium influx mechanisms in vascular smooth muscle cells (VSMCs) encompass the diverse pathways through which calcium ions enter the cytosol to trigger contraction and regulate cellular functions [StatPearls: Calcium Channel Blockers]. The primary pathway involves voltage-gated calcium channels (VGCCs), particularly the L-type Cav1.2 channel, which opens in response to membrane depolarization [PubMed: PMC2885005]. Other critical mechanisms include store-operated calcium entry (SOCE), mediated by STIM1 and Orai1, and receptor-operated calcium entry (ROCE), often involving the Transient Receptor Potential (TRP) channel family [PubMed: PMC3579373, Pharmacological Reviews: TRP channels]. These pathways are essential for maintaining vascular tone and systemic blood pressure, but their dysregulation is a key driver in the pathogenesis of hypertension, atherosclerosis, and pulmonary arterial hypertension [Circulation Research: VSMC in Hypertension]. Pharmacological intervention typically targets these mechanisms using calcium channel blockers (CCBs) like amlodipine and diltiazem, which are widely used to treat cardiovascular disorders by inducing vasodilation [NIH: LiverTox - Calcium Channel Blockers]. Beyond contraction, these calcium influx pathways also influence VSMC proliferation and migration, making them targets for preventing vascular remodeling and restenosis [Journal of Molecular and Cellular Cardiology]. Emerging therapies are exploring the inhibition of specific TRP and Orai channels to provide more selective control over vascular remodeling without the systemic side effects of traditional CCBs [Nature: Calcium signaling].
Inhibition of calcium ion influx through voltage-dependent or store-operated channels to promote vasodilation and reduce vascular resistance.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle cell calcium influx mechanisms (VSMC Ca2+ influx).